The term MGA inhibitors refers to a class of chemical compounds designed to target and modulate the activity of MGA (MAX gene-associated) proteins, which play a crucial role in the regulation of various cellular processes. MGA proteins are transcriptional regulators that belong to the b-HLH-LZ (basic Helix-Loop-Helix-Leucine Zipper) family. They are involved in the control of gene expression by acting as transcription factors, binding to specific DNA sequences and influencing the transcription of downstream target genes. MGA proteins are known to interact with other key transcriptional regulators such as MAX and MYC, forming intricate complexes that regulate gene expression networks. These interactions are vital for the maintenance of cellular homeostasis and proper cell growth. MGA inhibitors are designed to modulate the function of MGA proteins by disrupting their interactions with other regulatory molecules or DNA, ultimately affecting the transcriptional activity of the associated target genes.
The development of MGA inhibitors involves a detailed understanding of the molecular interactions and structural characteristics of MGA proteins. Researchers employ computational methods, structural biology, and chemical synthesis to design compounds that can selectively bind to specific regions of MGA proteins, thereby interfering with their normal function. By doing so, these inhibitors have the potential to provide valuable insights into the intricate regulatory networks involving MGA proteins and their associated partners. Additionally, these inhibitors could serve as valuable research tools to dissect the functional roles of MGA in various biological contexts. Overall, the exploration of MGA inhibitors contributes to advancing our understanding of gene regulation and cellular processes, offering potential avenues for further uncovering the complexities of transcriptional control.
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine | 1032900-25-6 | sc-505041 | 1 mg | $230.00 | ||
Targets ALK kinase and certain mutant forms of EGFR, hindering growth and survival of ALK-positive lung cancer cells. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | $172.00 $964.00 | 2 | |
Inhibits multiple tyrosine kinases including BCR-ABL and VEGFR, used in resistant cases of CML and Philadelphia chromosome-positive ALL. |